Urogen Pharma Stock Technical Analysis
| URGN Stock | USD 11.01 0.27 2.51% |
As of the 31st of January, UroGen Pharma has the Coefficient Of Variation of (2,323), risk adjusted performance of (0.03), and Variance of 6.86. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of UroGen Pharma, as well as the relationship between them.
UroGen Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as UroGen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to UroGenUroGen |
UroGen Pharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 39.93 | Strong Buy | 6 | Odds |
Most UroGen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand UroGen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of UroGen Pharma, talking to its executives and customers, or listening to UroGen conference calls.
UroGen Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
UroGen Pharma Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of UroGen Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
UroGen Pharma Trend Analysis
Use this graph to draw trend lines for UroGen Pharma. You can use it to identify possible trend reversals for UroGen Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual UroGen Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.UroGen Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for UroGen Pharma applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that UroGen Pharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 52.29, which is the sum of squared deviations for the predicted UroGen Pharma price change compared to its average price change.About UroGen Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of UroGen Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of UroGen Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on UroGen Pharma price pattern first instead of the macroeconomic environment surrounding UroGen Pharma. By analyzing UroGen Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of UroGen Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to UroGen Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 1.38 | 1.44 | 1.29 | 1.36 | Days Of Inventory On Hand | 206.25 | 221.2 | 254.38 | 241.66 |
UroGen Pharma January 31, 2025 Technical Indicators
Most technical analysis of UroGen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for UroGen from various momentum indicators to cycle indicators. When you analyze UroGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 1.56 | |||
| Mean Deviation | 1.93 | |||
| Coefficient Of Variation | (2,323) | |||
| Standard Deviation | 2.62 | |||
| Variance | 6.86 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | 1.55 | |||
| Maximum Drawdown | 13.53 | |||
| Value At Risk | (4.98) | |||
| Potential Upside | 4.77 | |||
| Skewness | (0.18) | |||
| Kurtosis | 0.7827 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UroGen Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UroGen Pharma. If investors know UroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UroGen Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.02) | Revenue Per Share | Quarterly Revenue Growth 0.209 | Return On Assets | Return On Equity |
The market value of UroGen Pharma is measured differently than its book value, which is the value of UroGen that is recorded on the company's balance sheet. Investors also form their own opinion of UroGen Pharma's value that differs from its market value or its book value, called intrinsic value, which is UroGen Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UroGen Pharma's market value can be influenced by many factors that don't directly affect UroGen Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UroGen Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if UroGen Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UroGen Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.